Burjeel Holdings Plc · ADX:BURJEEL
Burjeel — Investor Presentation (August 2025)
53 slides from Burjeel's investor presentation, August 2025
Slide 1: Burjeel Holdings
August 2025 Burjeel Holdings Leading Super-Specialty Healthcare Provider in the MENA Region
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by Burjeel Holdings PLC None of the Company or its subsidiaries or any of their affiliates or based on publicly available information and non-public advisors make any representation or warranty as to the fairness, information to assist you in making a p
Slide 3: Contents
Contents 02 03 Investment Strategic Case Priorities 01 Burjeel Holdings at a Glance 04 Performance Update 06 05 Appendix Guidance
Slide 4: Burjeel Holdings at a Glance
01 Burjeel Holdings at a Glance Leading Super-Specialty Healthcare Provider in MENA
Slide 5: Leading Integrated Healthcare Network in the MENA
Leading Integrated Healthcare Network in the MENA Expanding market presence UAE, Oman & KSA 112 19% Geographical Medical assets Inpatient market presence incl. 20 hospitals1 share in the UAE2 1,743 6.5 million 1,775 Bed capacity3 Total patients4 Doctors3 Diversified portfolio of brands AAA ESG MSCI
Slide 6: Milestones Over the Last 12 Months Driving Unmatched Growth & Complex Care Leadership
Milestones Over the Last 12 Months Driving Unmatched Growth & Complex Care Leadership Expanding Advancing Complex Care Embedding Medical Building Global Healthcare Network Capabilities Excellence & Innovation Partnerships Advanced Oncology & UAE’s Largest UAE’s 1st 15 Day Surgery Centers Oncology AB
Slide 7: High Quality, Large-scale Portfolio of Assets Across Geographies
High Quality, Large-scale Portfolio of Assets Across Geographies Segmental revenue contribution Geographic revenue contribution Hospital Medical Centers 1% Pharmacies Physiotherapy 87% Dubai & 9% 88% centers Northern 1% Other Emirates Abu Dhabi, Hospitals Al Dhafra & Al Ain 10% Medical Centers 4% Om
Slide 8: Business Model
1 2 Business 1 Differentiating capabilities Model • Level I & II Trauma Center • Centralised Lab Serving all • Level III Tertiary NICU • Nuclear Medicine socio-economic • Physio & Rehab Care • Department of Thalassemia groups • Intraoperative MRI • Advanced Center for Research • Da Vinci Xi robotic
Slide 9: Transforming Cancer Care: The UAE's Leading National Network
5 Expanding geographically Transforming Cancer Care: The UAE’s Leading National Network Burjeel Cancer Institute Diversified Referral Pathways Clinical Governance (Burjeel Medical City) Strengthening Oncology Access & Research Hub for high-end specialized oncology treatments Pathology, AI & Molecula
Slide 10: Advancing Women & Children's Healthcare Offering
Advancing Women & Children’s Healthcare Offering Partnered with the "Father of Fetal The UAE’s largest fertility center, Medicine," to provide fetal care for high- which commenced operations in risk pregnancies. First in MENA to September 2024 and became fully perform in-utero spina bifida repair. o
Slide 11: Strategic Priorities
02 Strategic Priorities Leading Super-Specialty Healthcare Provider in MENA
Slide 12: Ramp-up of Growth Assets, Operational Excellence, Solidify Leadership
5 Expanding geographically Ramp-up of Growth Assets Operational Excellence • Use young asset fleet to drive • Invest in clinical and nursing volume through enhanced utilization teams to enhance patient care • Position Burjeel Medical City • Lead in medical education as a primary growth driver and gl
Slide 13: Strategic Growth Pillars
5 Expanding geographically Strategic Growth Pillars Ramp-up of Growth Assets Increasing Patient Yield Operational Excellence Geographic Expansion Group Revenue Patient Yield Group EBITDA Margin Revenue from UAE Expansion Single 12-14% ‘24 5,010 Mid-Term ‘24 754 Digit Mid-Term ‘24 18% 25-27% Mid-Term
Slide 14: Investment Case
03 Investment Case Leading Super-Specialty Healthcare Provider in MENA
Slide 15: Investment Case Highlights
World-class super- Expanding geographically specialty care through high-return and driving patient yield growth low-CAPEX opportunities Accelerating Leading position in large, growing, & digitization resilient market to drive operational and medical excellence Well-invested multi- Cash-generative br
Slide 16: Differentiated Growth Strategy to Drive Complex Care Across Burjeel's UAE Network
1 World-class super-specialty care Differentiated Growth Strategy to Drive Complex Care Across Burjeel’s UAE Network DSCs optimize Burjeel Hospitals’ bed capacity Burjeel BMC Complex for complex care, with over 60% of elective 6 Hospitals 400 Care Beds surgeries feasible as same-day procedures Burje
Slide 17: Super-Specialty Care Offering Driving Patient Yields
51 World-classgeographically Expanding super-specialty care Super-Specialty Care Offering Driving Patient Yields Unmatched Da Vinci Xi system Momentum in Scaling Maximizing Patient Growth & Yield Innovation & Expertise Multi-Organ & Bone Marrow Transplants Liver & Kidney Transplants 60 (100% success
Slide 18: Advancing Specialized Care Through Innovation
1 World-class super-specialty care Advancing Specialized Care Through Innovation Transforming Limb Restoration Recent Breakthroughs in Complex Care The Middle East’s First Osseointegration Clinic Revolutionary solution Global access at lower cost: for amputees: direct Comparable to US ($95k–$150k) b
Slide 19: Trust Fertility Center: Rapid Ramp-Up
1 World-class super-specialty care Trust Fertility Center: Powering UAE’s Fertility Strategy with Rapid Ramp-Up Integral in Burjeel’s Women’s Health Platform H1 AED 27m Total 1,800+ Unique Patient 1,100+ IVF, FET, & IUI ~50% Clinical Pregnancy Rate 2025 Revenue Volumes Cycles Initiated (above global
Slide 20: Robust Talent Investments Powering Innovation & Research Capabilities
1 World-class super-specialty care Robust Talent Investments Powering Innovation & Research Capabilities Highly skilled and growing talent pool UAE’s Premier Research Hub: Advancing Science & Innovation +829 Doctors Axiom Space Partnership: Successfully completed an in-orbit research on 1,744 1,775
Slide 21: UAE Market Leader with a Prominent Position Across Segments
2 Leading position UAE Market Leader with a Prominent Position Across Segments Number of beds by key players1, as of December 2022 #1 inpatient platform in the UAE by private market volumes Beds excl. LTC in UAE 1,660 3 135 1,361 Beds in Oman 1,161 1,077 1,071 300 Focus on specialised and complex LT
Slide 22: Large, Growing & Resilient Addressable Market
2 Leading position Large, Growing & Resilient Addressable Market FY 2022 UAE & Oman & KSA market size1 $104bn Total healthcare expenditure (USD bn) 132 GCC market size2 112 $85bn UAE & Oman & KSA market size1 85 93 1.9x $27bn 69 UAE & Oman market size1 $1.4bn Burjeel Holdings revenue (FY 2024) 2021
Slide 23: Unique Business Model Leveraging Multiple Touchpoints
3 Well-invested multi-brand network Unique Business Model Leveraging Multiple Touchpoints CAPEX spent from inception to FY'24 AED 4.7bn Well-invested and a full-scale hub-and-spoke model enables the Group to capture value across the entire patient pathway through multiple touchpoints – driving reven
Slide 24: Leading Brand Portfolio Serving Entire Socioeconomic Spectrum
3 Well-invested multi-brand network Leading Brand Portfolio Serving Entire Socioeconomic Spectrum Brands 12 Hospitals2 2 Hospitals 2 Hospitals Assets1 4 Hospitals 9 Medical centers 1 Medical center 4 Medical centers 13 Medical centers 1 Homecare services center High income Middle class Mid to low-in
Slide 25: High-Growth Asset Mix with Significant Utilization Runway
4 High-growth asset mix High-Growth Asset Mix with Significant Utilization Runway Asset maturity split for hospitals1 Burjeel Medical City – significant opportunity to ramp up utilization with superior patient yields 37% Growth – high FY 2024 Mature Burjeel Hospital, Abu Dhabi High-Growth Burjeel Me
Slide 26: Multi-Pronged Expansion Strategy: Unlock Solid Growth Potential
5 Expanding geographically Multi-Pronged Expansion Strategy: Unlock Solid Growth Potential Key region of focus – UAE & KSA Expansion strategy pillars KSA to drive our geographic expansion Expanding World-Class Healthcare Network 1 Across Emerging UAE Communities Zero-capex expansion into Africa, thr
Slide 27: Expanding Reach, Enhancing Care: Burjeel's Growth Plan across the UAE
5 Expanding geographically Expanding Reach, Enhancing Care: Burjeel’s Growth Plan across the UAE Launch of 1 hospital, The Group will expand its Burjeel-branded network with a hospital, a day surgery center in 1 day surgery center, 11 specialized Dubai and the Northern Emirates, and 11 specialized m
Slide 28: Entering High-Potential Saudi Arabia Market Through Disruptive Healthcare Innovations
5 Expanding geographically Entering High-Potential Saudi Arabia Market Through Disruptive Healthcare Innovations PhysioTherabia – 30 Burjeel One – First Day Surgery Center in Riyadh centers launched Performance update1 across 10 cities Tabouk • Located in Irqah, Northwestern Riyadh, with an estimate
Slide 29: Operonix: Scaling Asset-Light Growth Through Strategic O&M Partnerships
5 Expanding geographically Operonix: Scaling Asset-Light Growth Through Strategic O&M Partnerships Approach Scope of Services 12% Contribution to H1’25 Partnering with Hospital O&M ER/Critical Care O&M 365k+ Net Profit Ministries of Health, Comprehensive hospital 24/7 Emergency and ICU Annual Patien
Slide 30: DOCKTOUR: Expanding Healthcare Access Across Africa with AD Ports
5 Expanding geographically DOCKTOUR: Expanding Healthcare Access Across Africa Through Strategic Partnership with AD Ports Mission to scale healthcare access Container Field Hospital in under-served regions in Africa Mobility Fast Deployment Easy to transport by land or sea, Delivered and installed
Slide 31: Leveraging Digital Transformation to Enhance Patient Experience
6 Accelerating digitization Leveraging Digital Transformation to Enhance Patient Experience and Maximise Operational Efficiency Strategic digital initiatives Key digital achievements Patient digital channel • Mid-term key investment areas in Digital Health Mobile application • Oracle Health informat
Slide 32: Optimizing Revenue Cycle Efficiency Through AI-Powered Coding & Analytics
6 Accelerating digitization Optimizing Revenue Cycle Efficiency Through AI-Powered Coding & Analytics AI-Driven Eligibility Engine AI Dashboard Capabilities Denial reduction ICD Validation Prevents denial root causes and ensures Reads and analyses ICDs in the claim compliance with guidelines and reg
Slide 33: Cash-Generative Business Model Enabling Consistent Shareholder Return
7 Cash-generative business model Cash-Generative Business Model Enabling Consistent Shareholder Return Financial performance underpinned Robust margin expansion drivers by operational excellence Healthy payer-mix with proportion Significant capacity to ramp-up of Thiqa patients increasing high growt
Slide 34: Strong Leadership with Well-Established Market-Oriented Corporate Governance
8 Commitment to ESG Strong Leadership with Well-Established Market-Oriented Corporate Governance Highly experienced leadership with focus on growing shareholder value Strong governance framework BoD of 7 Members Committees: A N B A A N 1 Female Board B Business Development & Director Sustainability
Slide 35: Strategic Pillars – ESG Framework
8 Commitment to ESG Strategic Pillars – ESG Framework System Community Governance Environment Diversity Equity & Inclusion Community Engagement Corporate Governance GHG Emissions & Carbon Neutrality 1 Increase the representation of women in 1 To touch >7 million lives per year by 2026 1 Maintain a h
Slide 36: FY 2024 ESG Highlights
8 Commitment to ESG FY 2024 ESG Highlights System Community Governance Environment 95% 87% Zero -29% Employee Inpatient Data breaches, corruption or GHG satisfaction score satisfaction score bribery and whistleblowing cases emission 54% 100% 100% -35% Women in Healthcare staff completed Hospitals in
Slide 37: Performance Update
04 Performance Update Leading Super-Specialty Healthcare Provider in MENA
Slide 38: Patient Growth Accelerates with Expanding Market Presence
Patient Growth Accelerates with Expanding Market Presence Group Inpatient Footfall, k Group Outpatient Footfall, k % bed occupancy % OP utilisation 65% 69% 64% 69% • The Group delivered strong inpatient footfall 69% 68% 69% 65% • Outpatient footfall growth accelerated to growth in Q2’25, supported b
Slide 39: Strong Growth Momentum Across Segments
Strong Growth Momentum Across Segments Along with Investments in Future Patient Growth Group Revenue, AED m Group EBITDA, AED m YoY YoY • Top-line growth accelerated in Q2’25, EBITDA margin • Group EBITDA grew YoY in Q2’25, driven by 1,403 +18.7% +59.4% fueled by strong patient footfall growth stron
Slide 40: Burjeel Medical City: Scaling Patient Base & Driving Efficiency Gains
5 Expanding geographically Burjeel Medical City: Scaling Patient Base & Driving Efficiency Gains Total patients, k Revenue, AED m1 EBITDA, AED m1 % bed occupancy % EBITDA margin 59% 68% 57% 67% 16.6% 17.6% 16.2% 17.3% +13.0% +22.6% 648 +20.8% 301 574 112 246 93 +30.4% +14.7% +21.3% 333 161 291 59 12
Slide 41: Top-Line Growth Underpinned by Cost Discipline & Strategic Asset Control
Top-Line Growth Underpinned by Cost Discipline & Strategic Asset Control Group OPEX Breakdown, % of Revenue Group EBITDA Analysis, AED m % EBITDA margin 84.2% 86.2% 83.4% 84.7% 16.2% 21.8% 82.0% 13.0% 12.3% 10.4% 11.1% 11.3% +221 (87) 2.0% 3.0% 3.9% 3.5% 1.9% (65) 25.0% 24.6% 25.7% 25.0% 25.2% +69 3
Slide 42: Strong Cash Flow Conversion & Profit Expansion
Strong Cash Flow Conversion & Profit Expansion Cash Flow from Operating Activities, AED m Group Net Profit Analysis, AED m % FCF conversion2 % Net profit margin 64% 42% 51% 51% 49% 54% 5.5% 10.5% +221 (176) 566 500 358 148 328 +69 212 229 (15) (7) (9) 65 2021 2022 2023 2024 H1'24 H1'25 Q2’24 Revenue
Slide 43: Well-Capitalized Balance Sheet Supporting Growth & Value Creation
Well-Capitalized Balance Sheet Supporting Growth & Value Creation AED m FY 2023 FY 2024 Q2’25 Debt Maturity as of 30 June 2025 Bank balances and cash 170 238 155 287 280 Interest-bearing loans and borrowings 1,164 1,208 1,621 245 258 237 225 Bank overdrafts – -- -- Bank debt1 1,164 1,208 1,621 Net d
Slide 44: Guidance
05 Guidance Leading Super-Specialty Healthcare Provider in MENA
Slide 45: Maintaining Growth Momentum While Building Future Margin Strength
Maintaining Growth Momentum While Building Future Margin Strength FY 2025 (Updated) Mid-term (2027-2028) • UAE: 1 advanced care oncology center (Dubai), • UAE: 1 hospital (Dubai), 1 day surgery center (RAK), Expansion 1 fertility clinic (Al Ain), 6 medical centers 3 medical centers • KSA: 1 day surg
Slide 46: Appendix
06 Appendix Leading Super-Specialty Healthcare Provider in MENA
Slide 47: A Proven Track Record of Scale and Leadership
A Proven Track Record of Scale and Leadership 2007-2010 2015 2017 2019 2021 2023 First Hospital opened Medeor Brand New unique facility focused on minimal Launched New Clinical Research Launched The Paley Middle East Clinic, in 2007 under LLH Launch invasive surgeries and alternative Burjeel Hospita
Slide 48: GCC Healthcare Market Growth Drivers
GCC Healthcare Market Growth Drivers Under-penetration of healthcare expenditure 1 Strong economic growth 2 3 Favorable demographic trends vs developed countries CAGR ‘22-31E of GDP1 Healthcare expenditure as % of GDP1 +1.9% +31.9% +4% +3% +3% 4-5% 12% 19% CAGR ‘22-27E CAGR ‘22-27E of GCC UAE Oman K
Slide 49: Rapid Growth in Organ Transplants & Rising Cancer Care Demand in the UAE
Rapid Growth in Organ Transplants & Rising Cancer Care Demand in the UAE Organ transplant Oncology Total number of organ transplants performed in the UAE Total number of malignant cancer cases in UAE (k) CAGR 17-22 CAGR 2011-2022 5.0 Living 213 4.6 4.7 4.8 4.9 Deceased 184 16% 7.3% 4.0 4.1 71 3.6 3.
Slide 50: GCC Governments Drive Major Healthcare Transformation
GCC Governments Drive Major Healthcare Transformation UAE initiatives Oman Health Vision 2050 KSA Vision 2030 UAE Vision 2021 To achieve sustainable funding for Some of the key initiatives health research by ensuring national in the healthcare spectrum: Providing world-class healthcare and internati
Slide 51: Q2'25 / H1'25 Financial Summary
Q2’25 / H1’25 Financial Summary Group Financial Summary Segmental Financial Summary AED millions Q2’25 Q2’24 H1’25 H1‘24 AED millions Q2’25 Q2’24 H1’25 H1‘24 Revenue 1,403 1,182 2,677 2,387 Revenue 1,403 1,182 2,677 2,387 Inventories consumed (360) (295) (674) (597) Hospitals2 1,245 1,062 2,371 2,14
Slide 52: FY 2024 / 2023 Financial Summary
FY 2024 / 2023 Financial Summary Group financial summary Segmental financial summary2 AED millions FY’24 FY‘23 AED millions FY’24 FY‘23 Revenue 5,010 4,535 Revenue 5,010 4,535 Inventories consumed (1,269) (1,096) Hospitals3 4,406 4,026 Doctors’ and other employees’ salaries (2,186) (1,947) Medical C
Slide 53: IR Contacts
IR Contacts August 2025 Sergei Levitskii Director of Investor Relations sergei.levitskii@burjeelholdings.com T: +971 2 3041 111 ir@burjeelholdings.com F: +971 2 2222 363 M: +971 503802383 PO Box 7400, Abu Dhabi, UAE Investor Calendar Company Website
Burjeel Holdings — Investor Presentation (August 2025) on 6ix